Full Year Results 

Rapid integration aids Dechra Pharma

Rapid integration aids Dechra Pharma

A few days prior to release of its full-year results, Dechra Pharmaceuticals (DPH) announced that it had snapped up veterinary contract manufacturer Ampharmco LLC for around $30m (£24.6m). The deal for Texas-based Ampharmco will enable Dechra to bring manufacturing in-house for several products currently dependent on third-party sourcing.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now